Trade QGEN stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
QIAGEN N.V. (QGEN) is trading at US$43.33, down 2.37% today as of Sep 18, 16:00 EDT. The company has a market capitalisation of US$9.1B. Over the past 52 weeks, QGEN has traded between US$32.53 and US$57.82. On Syfe you can trade QGEN with $0 commission and add it to your watchlist.
| Previous close | US$44.38 |
|---|---|
| Market cap | US$9.1B |
| P/E ratio | 16.93 |
| 52-week range | US$32.53 – US$57.82 |
| Dividend yield | 0.81% |
| Volume | 1.75M |
| Exchange | US |
Add to Watchlist
Set Price Alert
QIAGEN N.V.
QIAGEN NV is a holding company, which engages in the provision of Sample to Insight solutions that enable customers to gain valuable molecular insights from samples containing the building blocks of life. Its sample technologies isolate and process DNA, RNA, and proteins from blood, tissue, and other materials. The company was founded by Detlev H. Riesner and Metin Colpan on April 29, 1996 and is headquartered in Venlo, the Netherlands.
Year: 1996
QIAGEN N.V. (QGEN) stock is trading at US$43.33, -2.37% from the previous close of US$44.38.
The market cap for QIAGEN N.V. (QGEN) stock is approximately US$9.1B.
The price-to-earnings ratio for QIAGEN N.V. (QGEN) is 16.93, based on the latest reported earnings.
The 52-week high for QIAGEN N.V. (QGEN) stock is US$57.82.
The 52-week low for QIAGEN N.V. (QGEN) stock is US$32.53.
Yes, QIAGEN N.V. (QGEN) pays a dividend. The trailing 12-month dividend yield is 0.81%.
Stay on top of QGEN
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
